
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-18BLTE3Power of Attorney for SEC Reporting
This filing is an exhibit containing a Power of Attorney granted by Wan-Shan Chen, a director of BELITE BIO, INC, to specific individuals. These individuals, including employees of the company and external legal counsel, are authorized to act as the undersigned's agent for SEC reporting purposes. Their responsibilities...
Mid CapBiotechnology
2026-03-18BLTE3Power of Attorney for SEC Reporting PurposesMEDIUM
This filing details a Power of Attorney granted by Yu-Hsin Lin, Chief Executive Officer and Director of BELITE BIO, INC, to specific individuals, including Hao-Yuan Chuang, Vincent Lin, Wuxiao Liang, and Rita Leigh Strom. The appointed attorneys-in-fact are authorized to act on behalf of Yu-Hsin Lin for all SEC filing ...
Mid CapBiotechnology
2026-03-18BLTE3Power of Attorney for SEC Reporting Purposes
This filing details a Power of Attorney granted by Gary Clark Biddle to Yu-Hsin Lin, Hao-Yuan Chuang, Vincent Lin, Wuxiao Liang, and Rita Leigh Strom. The appointed attorneys-in-fact are authorized to act on Mr. Biddle's behalf for all necessary actions related to SEC filings, including obtaining EDGAR credentials, pre...
Mid CapBiotechnology
2026-03-18BLTE3Power of Attorney for SEC Reporting
This filing details a Power of Attorney granted by Ita Lu to Yu-Hsin Lin, Hao-Yuan Chuang, Vincent Lin, Wuxiao Liang, and Rita Leigh Strom. The attorneys-in-fact are authorized to act on behalf of Ita Lu for SEC reporting purposes, including obtaining EDGAR credentials, managing the EDGAR account, and preparing, execut...
Mid CapBiotechnology
2026-03-18BLTE3Power of Attorney for SEC Reporting
This filing details a Power of Attorney granted by John Michael Longo to Yu-Hsin Lin, Hao-Yuan Chuang, Vincent Lin, Wuxiao Liang, and Rita Leigh Strom. The attorneys-in-fact are authorized to obtain credentials for the SEC's EDGAR system, manage the undersigned's EDGAR account, and prepare and file necessary SEC docume...
Mid CapBiotechnology
2026-03-18BLTE3Power of Attorney for SEC Reporting
This filing details a Power of Attorney granted by Xiao-Hui Chen, a director at BELITE BIO, INC, to Yu-Hsin Lin, Hao-Yuan Chuang, Vincent Lin, Wuxiao Liang, and Rita Leigh Strom. The appointed attorneys-in-fact are authorized to handle all necessary actions for SEC reporting requirements, including obtaining EDGAR cred...
Mid CapBiotechnology
2026-03-18BLTE3Hao-Yuan Chuang Form 3 Filing and Power of Attorney for Belite Bio, IncMEDIUM
This SEC Form 3 filing reports the initial beneficial ownership of Hao-Yuan Chuang, Chief Financial Officer and Director of Belite Bio, Inc (BLTE). The filing discloses Chuang's ownership of 100,000 American Depositary Shares (each representing one ordinary share) and 195,264 ordinary shares directly. Additionally, the...
Mid CapBiotechnology
Sponsored
2026-03-18BLTE3Power of Attorney for SEC Reporting PurposesMEDIUM
This filing details a Power of Attorney granted by NATHAN L. MATA, Chief Scientific Officer of BELITE BIO, INC, to designated individuals. The attorneys-in-fact are authorized to obtain credentials for the SEC's EDGAR system, manage the undersigned's EDGAR account, and prepare, execute, and file various SEC forms inclu...
Mid CapBiotechnology
2026-03-18BLTE3Form 3 Filing for Belite Bio, Inc. - Ownership ChangeMEDIUM
This filing details changes in beneficial ownership for Belite Bio, Inc. (BLTE), specifically concerning Dr. Hendrik Peter Scholl, the Chief Medical Officer. The report includes information on stock options granted to Dr. Scholl, with vesting schedules and exercise prices detailed in footnotes. These options are for th...
Mid CapBiotechnology